New Hope for 50 Million People Worldwide
The Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital (BWH) is a collaborative global pursuit to accelerate treatment, prevention, and cures for multiple sclerosis (MS), Alzheimer’s disease, ALS (Lou Gehrig’s disease), Parkinson’s disease, and brain tumors. The center is dedicated to fueling life-giving breakthroughs and inspiring hope for future generations of patients and families who suffer.
Collectively, MS, Alzheimer’s, ALS, Parkinson’s disease and brain tumors impact more than 50 million people worldwide. Until recently, neurologic diseases have remained a mystery. However, thanks to new technological advances, the opportunities in the neurosciences today are truly extraordinary, observes BWH President Elizabeth Nabel, MD.
The Ann Romney Center for Neurologic Diseases is co-directed by Howard Weiner, MD, and Dennis Selkoe, MD. The leaders have nearly 30 years of experience harnessing the power of collaboration to drive innovation and solve major neurological issues.
The Ann Romney Center will be located in the Brigham Building for the Future, a state-of the-art medical research space where patients, physicians and scientists will be united under one roof.
Learn how you can support the Ann Romney Center for Neurologic Diseases:http://BWHannromneycenter.org